У нас вы можете посмотреть бесплатно Comprehensive Evaluation of the ‘Impact of Cannabinoids’ on Prostate Cancer: Integrating PSA, PET/CT или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Tags: Prostate Cancer, Cancer, Cannabinoids, Quality of Life, Pain Relief, Cannabis Medicine Dr. Shiksha Gallow presents, “Comprehensive Evaluation of the ‘Impact of Cannabinoids’ on Prostate Cancer: Integrating PSA, PET/CT” at CannMed 2025. Background Prostate cancer is the fourth most common cancer globally, representing 7.3% of all cases and 14.1% of male cancers. This empirical study provides a thorough examination of how cannabinoids impact prostate cancer, covering PSA levels, PET/CT scans, and patient-reported outcomes. Objectives The objectives were to assess the influence of cannabinoids on PSA levels, metabolic activity, tumor size via PET/CT scans, and patient-reported outcomes like pain levels and quality of life. Methodology Using a quantitative approach within a positivist paradigm, participants were recruited from Cancer Care clinics in the Eastern Cape. Inclusion criteria required a prostate cancer diagnosis and specific medical history and cannabis usage adherence. From 125 eligible individuals, 90 participants were determined through sample size calculation. Data collection involved PSA data from pathology reports, PET/CT scan results, and regular patient surveys, utilizing validated tools such as the Brief Pain Inventory and EQ5D questionnaire. Ethical standards were strictly followed, with participants providing voluntary consent. Analysis using SPSS focused on primary objectives related to PSA outcomes and tumor size evaluating PET scans. The secondary objectives included the patient related outcomes such as improved pain relief and enhanced quality of life of patients. Learning Objectives: ⦾ The objectives are to assess the influence of cannabinoids on PSA levels, metabolic activity, tumor size via PET/CT scans, and patient-reported outcomes such as pain levels and quality of life. Learn More about CannMed: https://cannmedevents.com/ Sign Up for Our Newsletter: https://share.hsforms.com/1oi57oJDnRN...